Marinus Pharma Revenue and Competitors

Radnor, PA USA

Location

$238.1M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Marinus Pharma's estimated annual revenue is currently $15M per year.(i)
  • Marinus Pharma's estimated revenue per employee is $92,593
  • Marinus Pharma's total funding is $238.1M.

Employee Data

  • Marinus Pharma has 162 Employees.(i)
  • Marinus Pharma grew their employee count by 14% last year.

Marinus Pharma's People

NameTitleEmail/Phone
1
Sr. VP, Business Unit Lead, Rare Genetic Epilepsy FranchiseReveal Email/Phone
2
Executive Director, Corporate Strategy & Business DevelopmentReveal Email/Phone
3
SVP, Corporate & Business Development and Commercial PlanningReveal Email/Phone
4
SVP, Chemistry, Manufacturing & ControlsReveal Email/Phone
5
VP, BiometricsReveal Email/Phone
6
SVP, DevelopmentReveal Email/Phone
7
VP, Clinical DevelopmentReveal Email/Phone
8
VP Acute CareReveal Email/Phone
9
VP, Strategy and Business DevelopmentReveal Email/Phone
10
VP, Finance and ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Marinus Pharma?

Marinus Pharmaceuticals is a development-stage pharmaceutical company focused on drugs to treat serious neurological and psychiatric disorders. SMRI will support work on a preclinical compound to treat bipolar disorder that has been in-licensed from Yale University.

keywords:N/A

$238.1M

Total Funding

162

Number of Employees

$15M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Marinus Pharma News

2022-04-13 - Marinus Pharma (MRNS) Reports Publication of ZTALMY ...

Marinus Pharma (MRNS) Reports Publication of ZTALMY Phase 3 Marigold Trial Results. April 14, 2022 7:03 AM. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS)...

2022-03-30 - Fragile X Syndrome Clinical Trials Pipeline Offers Promising ...

... Marinus Pharmaceuticals, Novartis, Neuren Pharmaceuticals, Roche, Confluence Pharmaceuticals, Tetra Therapeutics, Healx, and others.

2022-03-22 - U.S. FDA approves Marinus Pharma's drug to treat seizures ...

March 18 (Reuters) - The U.S. health regulator has approved Marinus Pharmaceuticals Inc's (MRNS.O) lead drug to treat seizures associated...

2020-09-15 - Marinus scores in Phase III genetic epilepsy drug study, wins BARDA contract for IV formulation

Under the agreement, BARDA will fund up to $51 million of the $84 million contract for programs related to RSE development, including preclinical studies of IV ganaxolone in animal models and clinical development of the drug, including treatment of people exposed to nerve gas. Shares of Marinus ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.9M1810%N/A
#2
$43.2M271-1%N/A
#3
$86.8M4638%N/A
#4
$148M813-4%N/A
#5
$396.7M12884%N/A